Thursday, October 14, 2021 8:00:35 PM
Your critique is worth a response.
I appreciate what you said. Heres my reply. My analysis is NOT about trying to make a prediction for what happens next. It is a mistake to think thats what I'm presenting.
Ive learned, the more Ive studied, that the price action always has the potential to move in either direction. Sometimes the odds favor one direction. Like yesterday ,the odds looked to me like a bounce rally was set up and thats what we got today. Patterns can show the potential and the odds may become stronger for one direction over another. Sometimes the chart develops to a set up/inflection point like that,and is more easy to forecast. When I see these set ups I post it and sometimes feel strong enough about the set up that I might call it a forecast, like I did last night. and this week.
But the biggest mistake is for someone to make a full blown prediction. I dont do that.
But what I always do is I look at a chart for patterns IN Both Directions. If you are looking for track patterns, its a mistake to only look in one direction. I always analyze it for both directions, actually a third direction is sideways. I look for that too. The naysayers and haters who dont understand my TA chart work, call it nonsense,and they complain like you did,that my analysis is wishy washy saying up down or sideways.... People who think this is my analysis are not following my clear technical analysis at all. My analysis is often tedious to read all the math details. I understand that some folks might want to skim and skip over the thought process I take you through. Thats a problem for them because it leaves them failing to understand anything I'm describing.
I would like to believe that people who are following my chart work, are following my analysis vision closely, close enough to go look at the chart, read everything I describe ,and see the fine details I'm showing. and then watch the price action the next day and see if the price followed the track pattern.
Heres the next picture to watch now, as I see it.
I drew what I consider the Elliott Wave/Fibonacci math track patterns.like a road map. Lets see where price goes tomorrow.Today it ran precisely along the track pattern to precise targets.
The math patterns can forecast future targets, and I described those as well. They run in either direction.Its not me being wishy washy. The price has potential to run in either direction. and we'll have to see what comes next. IF I see a target to watch for ,like todays 18.25 area, its a target to watch , and maybe a target to make a trading decision or not. I didnt sell any today at 18.20, but I might consider selling a small piece at 19.25, depending on the moment. I'd rather sell a little at 20.20 or 21.20, but I cant forecast that far right now. I'd really like to trim some at 26 or 25. but I dont know if we will get that high in the current cycle. we shall see.
----------------------------------------------
I do appreciate your comment that my own reading of the Global,political climate is subjective, and depends on the stuff I'm reading, what info and who I choose to believe, youre right, thats a good point. SO I should preface what I say ,that according to this or that analyst/insider, this is what they are saying.
They are saying we will have a market crash in the coming month or few weeks. I dont know if that will happen or not, but I want to be cautious. Others can whistle past the graveyard as they wish.
Anyway, I hope this helps sincere people understand that I am not trying to make predictions. I'm trying to show the technical roadmap and track patterns as I see them.IN Both directions.
https://www.screencast.com/t/ifgWnHDHT
I appreciate what you said. Heres my reply. My analysis is NOT about trying to make a prediction for what happens next. It is a mistake to think thats what I'm presenting.
Ive learned, the more Ive studied, that the price action always has the potential to move in either direction. Sometimes the odds favor one direction. Like yesterday ,the odds looked to me like a bounce rally was set up and thats what we got today. Patterns can show the potential and the odds may become stronger for one direction over another. Sometimes the chart develops to a set up/inflection point like that,and is more easy to forecast. When I see these set ups I post it and sometimes feel strong enough about the set up that I might call it a forecast, like I did last night. and this week.
But the biggest mistake is for someone to make a full blown prediction. I dont do that.
But what I always do is I look at a chart for patterns IN Both Directions. If you are looking for track patterns, its a mistake to only look in one direction. I always analyze it for both directions, actually a third direction is sideways. I look for that too. The naysayers and haters who dont understand my TA chart work, call it nonsense,and they complain like you did,that my analysis is wishy washy saying up down or sideways.... People who think this is my analysis are not following my clear technical analysis at all. My analysis is often tedious to read all the math details. I understand that some folks might want to skim and skip over the thought process I take you through. Thats a problem for them because it leaves them failing to understand anything I'm describing.
I would like to believe that people who are following my chart work, are following my analysis vision closely, close enough to go look at the chart, read everything I describe ,and see the fine details I'm showing. and then watch the price action the next day and see if the price followed the track pattern.
Heres the next picture to watch now, as I see it.
I drew what I consider the Elliott Wave/Fibonacci math track patterns.like a road map. Lets see where price goes tomorrow.Today it ran precisely along the track pattern to precise targets.
The math patterns can forecast future targets, and I described those as well. They run in either direction.Its not me being wishy washy. The price has potential to run in either direction. and we'll have to see what comes next. IF I see a target to watch for ,like todays 18.25 area, its a target to watch , and maybe a target to make a trading decision or not. I didnt sell any today at 18.20, but I might consider selling a small piece at 19.25, depending on the moment. I'd rather sell a little at 20.20 or 21.20, but I cant forecast that far right now. I'd really like to trim some at 26 or 25. but I dont know if we will get that high in the current cycle. we shall see.
----------------------------------------------
I do appreciate your comment that my own reading of the Global,political climate is subjective, and depends on the stuff I'm reading, what info and who I choose to believe, youre right, thats a good point. SO I should preface what I say ,that according to this or that analyst/insider, this is what they are saying.
They are saying we will have a market crash in the coming month or few weeks. I dont know if that will happen or not, but I want to be cautious. Others can whistle past the graveyard as they wish.
Anyway, I hope this helps sincere people understand that I am not trying to make predictions. I'm trying to show the technical roadmap and track patterns as I see them.IN Both directions.
https://www.screencast.com/t/ifgWnHDHT
Recent AVXL News
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 12/12/2025 09:05:00 PM
- Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference • GlobeNewswire Inc. • 11/26/2025 12:30:00 PM
